Cargando…

Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes

Background: Type 1 Diabetes mellitus (T1DM) is a well-known condition associated with low bone mineral density (BMD) and bone fracture, in which one of the risk factor is impaired endogenous insulin secretion. However, the association between the rate of impaired insulin secretory capacity in T1DM a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Masaki, Urai, Shin, Fukuoka, Hidenori, Hirota, Yushi, Yamamoto, Masaaki, Yamamoto, Naoki, Shichi, Hiroki, Fujita, Yasunori, Kanie, Keitaro, Iguchi, Genzo, Takahashi, Yutaka, Wataru, Ogawa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089665/
http://dx.doi.org/10.1210/jendso/bvab048.557
_version_ 1783687093278474240
author Suzuki, Masaki
Urai, Shin
Fukuoka, Hidenori
Hirota, Yushi
Yamamoto, Masaaki
Yamamoto, Naoki
Shichi, Hiroki
Fujita, Yasunori
Kanie, Keitaro
Iguchi, Genzo
Takahashi, Yutaka
Wataru, Ogawa
author_facet Suzuki, Masaki
Urai, Shin
Fukuoka, Hidenori
Hirota, Yushi
Yamamoto, Masaaki
Yamamoto, Naoki
Shichi, Hiroki
Fujita, Yasunori
Kanie, Keitaro
Iguchi, Genzo
Takahashi, Yutaka
Wataru, Ogawa
author_sort Suzuki, Masaki
collection PubMed
description Background: Type 1 Diabetes mellitus (T1DM) is a well-known condition associated with low bone mineral density (BMD) and bone fracture, in which one of the risk factor is impaired endogenous insulin secretion. However, the association between the rate of impaired insulin secretory capacity in T1DM and BMD remains to be elucidated. Objective: To clarify the effect of the rate of impaired insulin secretion on BMD in T1DM. Patients and Methods: This a retrospective single-center cross-sectional study, in which consecutive one-hundred seventy Japanese patients with T1DM at Kobe University Hospital were registered. According to the diagnostic criteria of The Japan Diabetes Society, patients were stratified into three subtypes; acute-onset (AO) (n =51, male 25%, 39 ± 15 years), slowly-progressive (SP) (n =37, male 37%, 57 ± 14 years), and fulminant (F) (n =12, male 33%, 51 ± 15 years) mainly by insulin secretory capacity at onset of T1DM. Lumbar spine (LS) and femoral neck (FN) BMD Z-score between three groups were evaluated. Results: The LS BMD is lower in AO than SP (p =0.03), while no differences were observed compared to F (SP/AO/F; 0.38 ± 1.08/-0.25 ± 0.96/-0.35 ± 1.01). The FN BMD also tended to be lower in AO than in SP (p =0.08) and in F (p =1.00) (SP/AO/F;0.03 ± 1.01/-0.44 ± 0.96/-0.35 ± 0.70). To identify the factors associated with decreased BMD, the multivariate regression analysis was performed using AO and SP. The LS BMD was associated with the pathogenic group (p =0.01). Since a negative correlation was seen between durations and CPR both in AO and SP group (p <0.01, p <0.01), we divided these subjects into following 5 groups; 1 to 4, 5 to 9, 10 to 14, 15 to 19, and more than 20 years. In these groups, the CPR was lower in AO than in SP in 1 to 4 years (p <0.01). Intriguingly, LS BMD was started to decline in 5 to 9 years (p =0.03) and was still continued in 10 to 14 years (p =0.01). In FN, BMD was started to decline in 10 to 14 years (p =0.01), suggesting the BMD decline followed by impaired insulin secretion. However, the difference of both BMD and CPR between AO and SP groups were not seen in more than 15 years group, indicating this tangent BMD difference is link to the difference of insulin secretion. Conclusions: This study firstly showed that pathogenic subtypes of T1DM differently affected on BMD. A detailed examination of each disease period showed that BMD continued to decrease as impaired insulin secretion.
format Online
Article
Text
id pubmed-8089665
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80896652021-05-06 Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes Suzuki, Masaki Urai, Shin Fukuoka, Hidenori Hirota, Yushi Yamamoto, Masaaki Yamamoto, Naoki Shichi, Hiroki Fujita, Yasunori Kanie, Keitaro Iguchi, Genzo Takahashi, Yutaka Wataru, Ogawa J Endocr Soc Bone and Mineral Metabolism Background: Type 1 Diabetes mellitus (T1DM) is a well-known condition associated with low bone mineral density (BMD) and bone fracture, in which one of the risk factor is impaired endogenous insulin secretion. However, the association between the rate of impaired insulin secretory capacity in T1DM and BMD remains to be elucidated. Objective: To clarify the effect of the rate of impaired insulin secretion on BMD in T1DM. Patients and Methods: This a retrospective single-center cross-sectional study, in which consecutive one-hundred seventy Japanese patients with T1DM at Kobe University Hospital were registered. According to the diagnostic criteria of The Japan Diabetes Society, patients were stratified into three subtypes; acute-onset (AO) (n =51, male 25%, 39 ± 15 years), slowly-progressive (SP) (n =37, male 37%, 57 ± 14 years), and fulminant (F) (n =12, male 33%, 51 ± 15 years) mainly by insulin secretory capacity at onset of T1DM. Lumbar spine (LS) and femoral neck (FN) BMD Z-score between three groups were evaluated. Results: The LS BMD is lower in AO than SP (p =0.03), while no differences were observed compared to F (SP/AO/F; 0.38 ± 1.08/-0.25 ± 0.96/-0.35 ± 1.01). The FN BMD also tended to be lower in AO than in SP (p =0.08) and in F (p =1.00) (SP/AO/F;0.03 ± 1.01/-0.44 ± 0.96/-0.35 ± 0.70). To identify the factors associated with decreased BMD, the multivariate regression analysis was performed using AO and SP. The LS BMD was associated with the pathogenic group (p =0.01). Since a negative correlation was seen between durations and CPR both in AO and SP group (p <0.01, p <0.01), we divided these subjects into following 5 groups; 1 to 4, 5 to 9, 10 to 14, 15 to 19, and more than 20 years. In these groups, the CPR was lower in AO than in SP in 1 to 4 years (p <0.01). Intriguingly, LS BMD was started to decline in 5 to 9 years (p =0.03) and was still continued in 10 to 14 years (p =0.01). In FN, BMD was started to decline in 10 to 14 years (p =0.01), suggesting the BMD decline followed by impaired insulin secretion. However, the difference of both BMD and CPR between AO and SP groups were not seen in more than 15 years group, indicating this tangent BMD difference is link to the difference of insulin secretion. Conclusions: This study firstly showed that pathogenic subtypes of T1DM differently affected on BMD. A detailed examination of each disease period showed that BMD continued to decrease as impaired insulin secretion. Oxford University Press 2021-05-03 /pmc/articles/PMC8089665/ http://dx.doi.org/10.1210/jendso/bvab048.557 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Bone and Mineral Metabolism
Suzuki, Masaki
Urai, Shin
Fukuoka, Hidenori
Hirota, Yushi
Yamamoto, Masaaki
Yamamoto, Naoki
Shichi, Hiroki
Fujita, Yasunori
Kanie, Keitaro
Iguchi, Genzo
Takahashi, Yutaka
Wataru, Ogawa
Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
title Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
title_full Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
title_fullStr Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
title_full_unstemmed Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
title_short Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
title_sort effects of the rate of impaired insulin secretion on bone mineral density in type 1 diabetes
topic Bone and Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089665/
http://dx.doi.org/10.1210/jendso/bvab048.557
work_keys_str_mv AT suzukimasaki effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT uraishin effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT fukuokahidenori effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT hirotayushi effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT yamamotomasaaki effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT yamamotonaoki effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT shichihiroki effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT fujitayasunori effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT kaniekeitaro effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT iguchigenzo effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT takahashiyutaka effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes
AT wataruogawa effectsoftherateofimpairedinsulinsecretiononbonemineraldensityintype1diabetes